BioSpace News Archive

Phase 3 confirmatory trials evaluate the safety and efficacy of using cryopreserved umbilical cord to achieve complete wound closure of non-healing DFUs with high-risk factors

Immunovia has today published third quarter interim report for January - September 2020 . It is available on Immunovia’s website . “The most important event during Q3 was that we announced positive results from the IMMray™ PanCan-d verification study. The analysis from the verification study showed results in line with th

ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in companion animals, announces that 10 investigation sites across the U.S. are now participating in the pivotal trial of ELIAS cancer immunotherapy.

Dr. Wood will launch next chapter of scientific discoveries and innovative medical services to continue to transform the lives of people with muscular dystrophy, ALS and related neuromuscular diseases

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced that Carmine Stengone, President and Chief Executive Officer, will present at the Stifel 2020 Virtual Healthcare Conference on Wednesday, November 18, at 2:00 p.m. ET / 11:00 a.m. PT. About Pipeline Therapeutics Pipeline Therapeutics is a biopha

Global developer of next-generation ultrasound solutions brings industry-leading Resona 7 Ultrasound System to largest member-driven healthcare performance improvement company in the country

Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, today announced the appointment of Chris Pricco as Chief Executive Officer (CEO) of Paradigm Specialty Networks, effective November 2 . Ken Hannigan , who has served as the division’s CEO for the past two years,

Kardium is pleased to announce the first clinical use of the Globe Positioning System – the new 3D mapping and navigation feature of its flagship product, the Globe® Mapping and Ablation System.

Eli Lilly and Company (NYSE:LLY) will participate in the Wolfe Research Virtual Healthcare Conference on Wednesday, November 18, 2020 . Joshua Smiley , senior vice president and Lilly’s chief financial officer, will participate in a virtual fireside chat at 1:30 p.m., Eastern Time . A live audio webcast will be available on t

Analysis from Phase 3 ATTR-ACT and Its Long-Term Extension Study Demonstrates VYNDAQEL ® 80 mg/VYNDAMAX ® 61 mg Significantly Improved Survival in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Compared to VYNDAQEL 20 mg